| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Sargramostim for active Crohn's disease. | N Engl J Med | 2005 | 2.24 |
| 2 | Phase I study of recombinant interleukin-21 in patients with metastatic melanoma and renal cell carcinoma. | J Clin Oncol | 2008 | 1.60 |
| 3 | A multicenter phase I trial of PX-866, an oral irreversible phosphatidylinositol 3-kinase inhibitor, in patients with advanced solid tumors. | Clin Cancer Res | 2012 | 1.43 |
| 4 | A patient tumor transplant model of squamous cell cancer identifies PI3K inhibitors as candidate therapeutics in defined molecular bins. | Mol Oncol | 2013 | 1.28 |
| 5 | Interferon lambda as a potential new therapeutic for hepatitis C. | Ann N Y Acad Sci | 2009 | 1.00 |